BioSpace News Archive

New targeted medication warnings address high risk clinical scenarios including hyperkalemia, QT prolongation, opioid use, pharmacogenomics; currently integrated in five hospital systems

Vizient announces it will create a centralized item master tool for a supply chain innovation program envisioned by the Captis® network of member hospitals and providers.

Vitalic Medical partners with VivaLNK to detect early signs of patient health deterioration and risk of falling

The Boulder Crest Institute for Posttraumatic Growth raised concerns this week about announcements made by the Marine Corps, Navy, and Special Operations Command (SOCOM) spotlighting a growing crisis in active duty military mental health.

Genome Medical, a leading nationwide telegenomics technology and services company, today announced it has expanded its clinical team by appointing clinical leads for each of its virtual specialty clinics in cancer, cardiovascular health, reproductive health, pediatrics and proactive health.

A new Healthcare IT Network Survey released today by Nyansa, Inc. based on a survey of Association for Executives in Healthcare Information Technology (AEHIT) members, revealed key insights to the host of challenges IT staff are facing as new digital and device technologies are being harnessed to enhance patient engagement, improve outcomes, speed service delivery and reduce costs.

As healthcare providers and plans continue to focus on curbing costs in 2019, adopting the best practices and technologies for a more preventive-based approach to health is a priority.

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today highlighted comments from an OncLive® article dated February 1, 2019 that an estimated majority of oncology patients do not have targetable genetic mutations that would make them eligible for targeted treatment.

OWC Pharmaceutical Research Corp., a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, issued a letter to shareholders.

Spok will showcase the latest evolution of Spok Care Connect® in booth #3371 at HIMSS19